164 related articles for article (PubMed ID: 3652754)
1. Prostaglandin E1 as a screening vasodilator in primary pulmonary hypertension.
Halpern SM; Shah PK; Lehrman S; Goldberg HS; Jasper AC; Koerner SK
Chest; 1987 Oct; 92(4):686-91. PubMed ID: 3652754
[TBL] [Abstract][Full Text] [Related]
2. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome.
Kunimoto F; Arai K; Isa Y; Koyano T; Kadoi Y; Saito S; Goto F
Anesth Analg; 1997 Sep; 85(3):507-13. PubMed ID: 9296401
[TBL] [Abstract][Full Text] [Related]
3. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in experimental porcine pulmonary hypertension.
Prielipp RC; McLean R; Rosenthal MH; Pearl RG
Crit Care Med; 1991 Jan; 19(1):60-7. PubMed ID: 1986891
[TBL] [Abstract][Full Text] [Related]
4. Effects of vasodilators on gas exchange in acute canine embolic pulmonary hypertension.
Delcroix M; Mélot C; Lejeune P; Leeman M; Naeije R
Anesthesiology; 1990 Jan; 72(1):77-84. PubMed ID: 2297136
[TBL] [Abstract][Full Text] [Related]
5. Inhaled aerosolized prostaglandin E1, pulmonary hemodynamics, and oxygenation during lung transplantation.
Della Rocca G; Coccia C; Pompei L; Costa MG; Di Marco P; Pietropaoli P
Minerva Anestesiol; 2008 Nov; 74(11):627-33. PubMed ID: 18971891
[TBL] [Abstract][Full Text] [Related]
6. Myocardial ischemia during vasodilator therapy in a canine model of pulmonary hypertension and coronary insufficiency.
Priebe HJ
Anesthesiology; 1992 May; 76(5):781-91. PubMed ID: 1575347
[TBL] [Abstract][Full Text] [Related]
7. Hemodynamic effects of diltiazem during vasoconstrictor pulmonary hypertension in sheep.
Pearl RG; Finn JC
Anesth Analg; 1990 Nov; 71(5):493-7. PubMed ID: 2221409
[TBL] [Abstract][Full Text] [Related]
8. [The effects of oxygen and vasodilators on pulmonary hemodynamics and blood gases in chronic lung disease].
Hirasima T; Matsumoto T; Hirata N; Kimura T; Fukuda K; Takenaka S; Shima K
Nihon Kyobu Shikkan Gakkai Zasshi; 1992 Sep; 30(9):1655-61. PubMed ID: 1447840
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E1 and intrapulmonary shunt in cardiac surgical patients with pulmonary hypertension.
Heerdt PM; Weiss CI
Ann Thorac Surg; 1990 Mar; 49(3):463-5. PubMed ID: 2106846
[TBL] [Abstract][Full Text] [Related]
10. Hemodynamic profiles of prostaglandin E1, isoproterenol, prostacyclin, and nifedipine in vasoconstrictor pulmonary hypertension in sheep.
Prielipp RC; Rosenthal MH; Pearl RG
Anesth Analg; 1988 Aug; 67(8):722-9. PubMed ID: 3293483
[TBL] [Abstract][Full Text] [Related]
11. Inhaled nitric oxide versus intravenous vasodilators in severe pulmonary hypertension after cardiac surgery.
Schmid ER; Bürki C; Engel MH; Schmidlin D; Tornic M; Seifert B
Anesth Analg; 1999 Nov; 89(5):1108-15. PubMed ID: 10553820
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of vasodilator therapy in canine model of acute pulmonary hypertension.
Priebe HJ
Am J Physiol; 1988 Nov; 255(5 Pt 2):H1232-9. PubMed ID: 3142278
[TBL] [Abstract][Full Text] [Related]
13. Vasodilator therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside.
Kieler-Jensen N; Lundin S; Ricksten SE
J Heart Lung Transplant; 1995; 14(3):436-43. PubMed ID: 7654728
[TBL] [Abstract][Full Text] [Related]
14. Cardiovascular effects of vasodilator therapy for pulmonary arterial hypertension.
Rubin LJ
Clin Chest Med; 1983 May; 4(2):309-19. PubMed ID: 6342925
[No Abstract] [Full Text] [Related]
15. Inhaled nitric oxide in primary pulmonary hypertension: a safe and effective agent for predicting response to nifedipine.
Ricciardi MJ; Knight BP; Martinez FJ; Rubenfire M
J Am Coll Cardiol; 1998 Oct; 32(4):1068-73. PubMed ID: 9768734
[TBL] [Abstract][Full Text] [Related]
16. Pulmonary hypertension in systemic lupus erythematosus: effect of vasodilators on pulmonary hemodynamics.
Mahowald ML; Weir EK; Ridley DJ; Messner RP
J Rheumatol; 1985 Aug; 12(4):773-7. PubMed ID: 4057200
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E1 in the adult respiratory distress syndrome. Benefit for pulmonary hypertension and cost for pulmonary gas exchange.
Mélot C; Lejeune P; Leeman M; Moraine JJ; Naeije R
Am Rev Respir Dis; 1989 Jan; 139(1):106-10. PubMed ID: 2912329
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin E1 in pulmonary hypertension of collagen disease.
Kawahara R; Takezawa J; Mike N; Fukui S; Nishimura M; Tachimori Y; Taenaka N; Yoshiya I
Crit Care Med; 1987 Sep; 15(9):884-5. PubMed ID: 3621967
[TBL] [Abstract][Full Text] [Related]
19. Vasodilator therapy in vasoconstrictor-induced pulmonary hypertension in sheep.
Prielipp RC; Rosenthal MH; Pearl RG
Anesthesiology; 1988 Apr; 68(4):552-8. PubMed ID: 3128144
[TBL] [Abstract][Full Text] [Related]
20. Hemodynamic effects of nifedipine in primary pulmonary hypertension.
Douglas JS
J Am Coll Cardiol; 1983 Jul; 2(1):174-9. PubMed ID: 6853910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
